These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27645371)

  • 41. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
    Hagag AA; Abdel-Lateef AE; Aly R
    J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala.
    Alvarez E; Seppa M; Rivas S; Fuentes L; Valverde P; Antillón-Klussmann F; Castellanos M; Sweet-Cordero EA; Messacar K; Kurap J; Bustamante M; Howard SC; Efron B; Luna-Fineman S
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28423236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.
    Gaynon PS; Steinherz PG; Bleyer WA; Ablin AR; Albo VC; Finklestein JZ; Grossman NJ; Novak LJ; Pyesmany AF; Reaman GH
    J Clin Oncol; 1993 Nov; 11(11):2234-42. PubMed ID: 8229139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India.
    Marwaha RK; Kulkarni KP; Bansal D; Trehan A
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):366-9. PubMed ID: 20502353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Keep in Mind Quality of Life: Outcome of a Ten-Year Series of Post-Transplantation Early Relapses in Childhood Acute Lymphoblastic Leukemia-A Report from the Grand Ouest Oncology Study Group for Children in France.
    Haro S; Tavenard A; Rialland F; Taque S; Guillerm G; Blouin P; Esvan M; Pellier I; Gandemer V
    Biol Blood Marrow Transplant; 2016 May; 22(5):889-94. PubMed ID: 26845034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of a modified induction chemotherapy in children with acute lymphoblastic leukemia].
    Pan C; Gu LJ; Xue HL; Chen J; Dong L; Zhou M; Luo CY; Wang YP; Tang JY
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):324-8. PubMed ID: 17697614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB; Sather HN; Sensel MG; Trigg ME; Cherlow JM; Lukens JN; Wolff L; Uckun FM; Gaynon PS
    N Engl J Med; 1998 Jun; 338(23):1663-71. PubMed ID: 9614257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
    Evans WE; Relling MV; Rodman JH; Crom WR; Boyett JM; Pui CH
    N Engl J Med; 1998 Feb; 338(8):499-505. PubMed ID: 9468466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treating leukemia in a resource poor setting.
    Menon J; Mathews L; Purushothaman KK
    Indian Pediatr; 2008 May; 45(5):410-2. PubMed ID: 18515933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    Meeske KA; Ji L; Freyer DR; Gaynon P; Ruccione K; Butturini A; Avramis VI; Siegel S; Matloub Y; Seibel NL; Sposto R
    Pediatr Blood Cancer; 2015 Dec; 62(12):2140-9. PubMed ID: 26173904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: a population-based study.
    Baker JM; To T; Beyene J; Zagorski B; Greenberg ML; Sung L
    Leuk Res; 2014 Feb; 38(2):204-9. PubMed ID: 24333116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource-rich developing country.
    Jastaniah W; Elimam N; Abdalla K; Iqbal BA; Khattab TM; Felimban S; Abrar MB
    Pediatr Blood Cancer; 2015 Jun; 62(6):945-50. PubMed ID: 25557583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X.
    Pui CH; Dodge RK; Look AT; George SL; Rivera GK; Abromowitch M; Ochs J; Evans WE; Crist WM; Simone JV
    J Clin Oncol; 1991 Aug; 9(8):1341-7. PubMed ID: 2072137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia.
    Nathan PC; Wasilewski-Masker K; Janzen LA
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1065-82, vi-vii. PubMed ID: 19825453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.